Drugs · acquisition-cost intelligence
olopatadine hydrochloride
· ingredient olopatadineAntiallergic agents, excl. corticosteroids· OLOPATADINE HYDROCHLORIDE 665 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.93959
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other olopatadine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| CVS Eye Allergy Itch Relief Twice Daily | $1.22 | +$0.28090 |
| Allergy Relief Eye Drops | $3.10 | +$2.16 |
| Allergy Relief Eye Drops | $6.17 | +$5.23 |
Medicare Part D coverage · CY2026
On 111 plan formularies · typical tier 4
Prior auth 0% · Step therapy 2% · Quantity limit 75% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.